are not the only choice in this setting. Leukotriene inhibitors should not be used to treat manifestations aside from asthma and sinonasal disease. Recommendation: For patients with EGPA, we conditionally recommend obtaining an echocardiogram at the time of diagnosis. Cardiac involvement is the major cause of diseaserelated mortality in EGPA Recommendation: For patients with EGPA, we conditionally recommend using the Five-Factor Score to guide therapy. The Five-Factor Score (FFS), first